Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Dara Aisner

Concepts (418)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
69
2026
2664
4.780
 Why?
Carcinoma, Non-Small-Cell Lung
48
2026
1189
3.820
 Why?
ErbB Receptors
22
2025
635
2.120
 Why?
Genetic Testing
9
2022
480
2.110
 Why?
Mutation
42
2026
4075
2.010
 Why?
Pathology, Molecular
7
2019
25
1.920
 Why?
High-Throughput Nucleotide Sequencing
16
2026
530
1.890
 Why?
Oncogene Proteins, Fusion
13
2019
212
1.790
 Why?
Protein Kinase Inhibitors
27
2026
981
1.770
 Why?
Molecular Diagnostic Techniques
3
2020
103
1.490
 Why?
Proto-Oncogene Proteins B-raf
13
2022
223
1.310
 Why?
Proto-Oncogene Proteins
17
2018
624
1.300
 Why?
Biomarkers, Tumor
21
2026
1321
1.280
 Why?
Neoplasms
13
2025
2906
1.270
 Why?
Protein-Tyrosine Kinases
12
2018
431
1.260
 Why?
Receptor Protein-Tyrosine Kinases
10
2019
231
1.020
 Why?
DNA, Neoplasm
3
2019
158
1.000
 Why?
Antineoplastic Agents
16
2024
2214
0.970
 Why?
Proto-Oncogene Proteins p21(ras)
11
2020
254
0.960
 Why?
Proto-Oncogene Proteins c-met
5
2019
76
0.860
 Why?
Drug Resistance, Neoplasm
13
2023
881
0.840
 Why?
Gene Rearrangement
14
2026
155
0.820
 Why?
Acrylamides
5
2025
74
0.760
 Why?
Molecular Targeted Therapy
12
2026
439
0.740
 Why?
Colorectal Neoplasms
3
2022
866
0.730
 Why?
Adenocarcinoma
9
2018
925
0.720
 Why?
Ganglioglioma
4
2014
34
0.690
 Why?
DNA Mutational Analysis
11
2020
407
0.660
 Why?
Brain Neoplasms
10
2018
1329
0.660
 Why?
Immunohistochemistry
11
2026
1716
0.640
 Why?
Aniline Compounds
4
2025
120
0.640
 Why?
Tumor Suppressor Protein p53
4
2026
534
0.630
 Why?
Humans
128
2026
145474
0.630
 Why?
Precision Medicine
4
2018
459
0.600
 Why?
Prognosis
15
2026
4316
0.600
 Why?
Adenocarcinoma, Mucinous
2
2022
76
0.600
 Why?
Insurance, Health, Reimbursement
1
2020
98
0.590
 Why?
Neoplasms, Muscle Tissue
1
2019
3
0.590
 Why?
Receptors, Nerve Growth Factor
1
2019
18
0.590
 Why?
Pyrazoles
10
2018
517
0.570
 Why?
Astrocytoma
3
2015
130
0.570
 Why?
Biological Products
1
2022
257
0.570
 Why?
Neoplasm Metastasis
10
2024
688
0.560
 Why?
Insurance Coverage
1
2020
244
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1963
0.540
 Why?
In Situ Hybridization, Fluorescence
13
2019
325
0.530
 Why?
Laboratory Proficiency Testing
2
2023
9
0.530
 Why?
Computational Biology
4
2023
669
0.500
 Why?
Medical Oncology
5
2026
339
0.470
 Why?
RNA
5
2019
910
0.470
 Why?
Pyrimidines
7
2025
530
0.420
 Why?
Smoking
3
2018
1472
0.420
 Why?
Neoplasm Staging
13
2024
1471
0.420
 Why?
Small Cell Lung Carcinoma
1
2016
122
0.420
 Why?
Aged, 80 and over
19
2026
8333
0.410
 Why?
ras Proteins
5
2015
150
0.400
 Why?
Mesothelioma
2
2024
51
0.390
 Why?
DNA Copy Number Variations
6
2026
184
0.380
 Why?
Pyridines
8
2016
609
0.380
 Why?
Aged
34
2026
26153
0.370
 Why?
AMP-Activated Protein Kinases
1
2014
192
0.370
 Why?
Endometrial Neoplasms
2
2026
205
0.370
 Why?
Neoplasm Recurrence, Local
3
2022
1149
0.360
 Why?
Female
55
2026
78844
0.340
 Why?
Laboratories
3
2025
110
0.340
 Why?
Middle Aged
42
2026
36215
0.340
 Why?
Telomerase
7
2002
246
0.340
 Why?
Male
53
2026
72842
0.330
 Why?
S100 Proteins
2
2014
35
0.330
 Why?
B7-H1 Antigen
2
2026
244
0.320
 Why?
Pleural Neoplasms
2
2024
30
0.320
 Why?
TOR Serine-Threonine Kinases
1
2014
454
0.320
 Why?
Neoadjuvant Therapy
3
2024
465
0.320
 Why?
Genomics
4
2023
825
0.310
 Why?
Sulfones
3
2015
127
0.300
 Why?
Glycine
3
2015
186
0.290
 Why?
Adult
37
2026
40777
0.280
 Why?
Curriculum
1
2016
1070
0.280
 Why?
Early Detection of Cancer
2
2019
485
0.270
 Why?
Adrenal Gland Neoplasms
2
2022
98
0.260
 Why?
Head and Neck Neoplasms
3
2019
561
0.260
 Why?
Indoles
6
2025
507
0.260
 Why?
Neoplasms, Multiple Primary
2
2022
58
0.250
 Why?
Oncogene Fusion
2
2019
11
0.250
 Why?
Gene Dosage
2
2018
145
0.250
 Why?
Class I Phosphatidylinositol 3-Kinases
4
2022
108
0.250
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2018
58
0.240
 Why?
Melanoma
2
2020
759
0.240
 Why?
Exons
5
2019
363
0.240
 Why?
Treatment Outcome
12
2024
11772
0.240
 Why?
Survival Analysis
5
2025
1374
0.240
 Why?
Antineoplastic Agents, Immunological
2
2018
198
0.240
 Why?
Genetic Predisposition to Disease
6
2019
2378
0.230
 Why?
Phosphatidylinositol 3-Kinases
4
2023
382
0.230
 Why?
Oncogenes
3
2016
118
0.230
 Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb
3
2015
8
0.220
 Why?
Thymoma
1
2025
37
0.220
 Why?
Thymus Neoplasms
1
2025
30
0.220
 Why?
Pemetrexed
1
2024
40
0.220
 Why?
Epithelioid Cells
2
2015
9
0.210
 Why?
Immunotherapy
5
2022
666
0.210
 Why?
Fetomaternal Transfusion
1
2023
10
0.200
 Why?
Sensitivity and Specificity
5
2019
1997
0.200
 Why?
Carcinoma, Squamous Cell
3
2019
641
0.190
 Why?
Choriocarcinoma
1
2022
9
0.190
 Why?
Endodermal Sinus Tumor
1
2022
10
0.190
 Why?
Cell Line, Tumor
11
2018
3542
0.180
 Why?
Pathologists
2
2023
19
0.180
 Why?
Tertiary Care Centers
1
2023
195
0.180
 Why?
Biopsy, Fine-Needle
2
2012
68
0.180
 Why?
Gene Fusion
2
2018
30
0.170
 Why?
Goals
1
2023
184
0.170
 Why?
Young Adult
13
2024
14218
0.170
 Why?
Cell Proliferation
7
2017
2507
0.170
 Why?
Neoplasms, Germ Cell and Embryonal
1
2022
76
0.170
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2022
41
0.170
 Why?
Patient Selection
4
2018
738
0.170
 Why?
Biopsy
4
2018
1082
0.170
 Why?
Hematologic Neoplasms
1
2023
168
0.170
 Why?
Carbazoles
1
2021
53
0.170
 Why?
Combined Modality Therapy
4
2018
1266
0.170
 Why?
Pheochromocytoma
1
2022
67
0.170
 Why?
United States
10
2025
16098
0.160
 Why?
Meningioma
1
2022
88
0.160
 Why?
Graft vs Host Disease
1
2023
279
0.160
 Why?
Trastuzumab
1
2021
118
0.160
 Why?
Glioblastoma
2
2015
353
0.160
 Why?
Laboratories, Hospital
1
2020
14
0.160
 Why?
Government Regulation
1
2020
39
0.160
 Why?
Pathology, Clinical
2
2017
29
0.160
 Why?
GTP Phosphohydrolases
1
2020
93
0.150
 Why?
Piperidines
1
2021
222
0.150
 Why?
Costs and Cost Analysis
1
2020
221
0.150
 Why?
Cell Transformation, Neoplastic
3
2018
337
0.150
 Why?
Stakeholder Participation
1
2020
84
0.150
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
2017
61
0.150
 Why?
Chromosome Aberrations
2
2019
166
0.150
 Why?
Genes, erbB-2
2
2015
32
0.140
 Why?
Smad4 Protein
1
2019
34
0.140
 Why?
Multiplex Polymerase Chain Reaction
1
2019
56
0.140
 Why?
Genetic Heterogeneity
1
2019
66
0.140
 Why?
Multigene Family
1
2019
210
0.140
 Why?
Breast Neoplasms, Male
1
2018
29
0.140
 Why?
Genetic Markers
1
2019
335
0.140
 Why?
Pyridazines
1
2018
57
0.140
 Why?
Database Management Systems
1
2018
51
0.130
 Why?
Retrospective Studies
12
2026
17291
0.130
 Why?
Genetic Association Studies
1
2019
369
0.130
 Why?
Gene Frequency
1
2019
487
0.130
 Why?
Cell Cycle Proteins
4
2015
630
0.130
 Why?
Piperazines
2
2018
375
0.130
 Why?
Quinazolines
3
2014
266
0.130
 Why?
Cell-Free Nucleic Acids
1
2018
33
0.130
 Why?
Thromboembolism
1
2018
129
0.130
 Why?
Skin Neoplasms
2
2020
849
0.130
 Why?
Pregnancy Complications
1
2023
602
0.130
 Why?
Programmed Cell Death 1 Receptor
2
2018
265
0.130
 Why?
Smokers
1
2018
138
0.130
 Why?
Gene Deletion
1
2019
391
0.130
 Why?
Radiotherapy, Intensity-Modulated
1
2018
142
0.130
 Why?
Imidazoles
1
2018
247
0.130
 Why?
Medical Informatics
1
2018
99
0.130
 Why?
Intraoperative Care
1
2017
63
0.130
 Why?
Leukemia, Myeloid, Acute
1
2024
686
0.120
 Why?
Chloroquine
1
2017
54
0.120
 Why?
Ovarian Neoplasms
1
2022
595
0.120
 Why?
Pleural Effusion, Malignant
1
2016
12
0.120
 Why?
Coculture Techniques
1
2017
247
0.120
 Why?
Small Molecule Libraries
1
2017
111
0.120
 Why?
Disease Progression
6
2024
2864
0.120
 Why?
Carcinogenesis
1
2017
228
0.120
 Why?
Immunity, Humoral
1
2016
118
0.110
 Why?
Codon
1
2016
92
0.110
 Why?
Proto-Oncogene Proteins c-kit
1
2016
72
0.110
 Why?
RNA, Messenger
4
2018
2803
0.110
 Why?
Sulfonamides
2
2017
583
0.110
 Why?
Clinical Decision-Making
1
2019
363
0.110
 Why?
Survival Rate
5
2026
2090
0.110
 Why?
Neoplastic Cells, Circulating
1
2016
81
0.110
 Why?
Protein Kinases
1
2017
312
0.110
 Why?
Triple Negative Breast Neoplasms
1
2018
218
0.110
 Why?
Fatal Outcome
1
2016
305
0.110
 Why?
Clinical Laboratory Techniques
1
2016
96
0.110
 Why?
Peritoneal Neoplasms
1
2016
104
0.110
 Why?
Oncogene Proteins
1
2015
62
0.110
 Why?
Amino Acid Substitution
1
2016
302
0.110
 Why?
Positron Emission Tomography Computed Tomography
1
2016
117
0.110
 Why?
Signal Transduction
5
2017
5216
0.110
 Why?
Sequence Analysis, RNA
1
2017
442
0.110
 Why?
Immunity, Cellular
1
2016
274
0.110
 Why?
Practice Guidelines as Topic
2
2019
1581
0.110
 Why?
Hamartoma
1
2015
29
0.110
 Why?
Genetic Variation
1
2019
972
0.110
 Why?
Pharmacogenetics
1
2016
175
0.110
 Why?
Meningeal Carcinomatosis
1
2014
7
0.110
 Why?
Spinal Cord Neoplasms
1
2014
41
0.100
 Why?
Health Care Surveys
1
2016
536
0.100
 Why?
Autophagy
1
2017
291
0.100
 Why?
Medicare
1
2020
903
0.100
 Why?
Speech Disorders
1
2014
29
0.100
 Why?
Mitogen-Activated Protein Kinases
1
2015
288
0.100
 Why?
Paresis
1
2014
30
0.100
 Why?
Deoxycytidine
1
2015
220
0.100
 Why?
Tumor Cells, Cultured
5
2019
886
0.100
 Why?
Multimodal Imaging
1
2015
129
0.100
 Why?
Polymerase Chain Reaction
2
2014
1041
0.100
 Why?
Receptor, trkA
1
2013
18
0.100
 Why?
Membrane Proteins
1
2020
1164
0.100
 Why?
Alternative Splicing
3
2017
247
0.100
 Why?
Liver Neoplasms
3
2015
776
0.100
 Why?
Microscopy, Electron
1
2014
414
0.100
 Why?
Dose-Response Relationship, Drug
5
2021
2028
0.100
 Why?
Wnt Signaling Pathway
1
2015
211
0.100
 Why?
Lung Transplantation
1
2016
332
0.100
 Why?
Intracranial Hemorrhages
1
2014
106
0.100
 Why?
Graft Rejection
1
2016
521
0.100
 Why?
Brain Stem Neoplasms
1
2013
87
0.090
 Why?
Serine Endopeptidases
1
2013
128
0.090
 Why?
Positron-Emission Tomography
1
2015
343
0.090
 Why?
Headache
1
2014
151
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2017
977
0.090
 Why?
Sarcoma
1
2015
207
0.090
 Why?
Gene Expression Regulation, Neoplastic
1
2019
1443
0.090
 Why?
Microtubule-Associated Proteins
1
2013
194
0.090
 Why?
Societies, Medical
4
2018
899
0.090
 Why?
Bone Neoplasms
1
2015
259
0.090
 Why?
Tissue Fixation
1
2012
37
0.090
 Why?
Recombinant Fusion Proteins
2
2013
666
0.090
 Why?
Gene Amplification
3
2019
118
0.090
 Why?
Mutation Rate
1
2011
33
0.090
 Why?
Predictive Value of Tests
2
2015
2121
0.090
 Why?
Lung
4
2015
4106
0.080
 Why?
Translocation, Genetic
1
2012
119
0.080
 Why?
Algorithms
1
2019
1845
0.080
 Why?
Interdisciplinary Communication
1
2012
200
0.080
 Why?
Tomography, X-Ray Computed
3
2018
2769
0.080
 Why?
Education, Medical, Graduate
1
2016
562
0.080
 Why?
Clinical Trials as Topic
3
2025
1061
0.080
 Why?
Specimen Handling
1
2012
182
0.080
 Why?
Teratoma
1
2011
124
0.080
 Why?
Epithelial Cells
1
2017
1131
0.080
 Why?
Rhabdoid Tumor
1
2011
102
0.080
 Why?
DNA-Binding Proteins
6
2011
1480
0.080
 Why?
Genome, Human
1
2012
420
0.080
 Why?
Terminology as Topic
1
2012
257
0.080
 Why?
Prospective Studies
2
2023
8057
0.080
 Why?
Phosphorylation
1
2014
1707
0.070
 Why?
Immunoenzyme Techniques
3
2015
200
0.070
 Why?
Erlotinib Hydrochloride
3
2014
72
0.070
 Why?
Xenograft Model Antitumor Assays
3
2019
934
0.070
 Why?
Breast Neoplasms
1
2022
2382
0.070
 Why?
Disease-Free Survival
3
2016
767
0.070
 Why?
Catheter Ablation
1
2012
355
0.070
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2008
17
0.070
 Why?
Diagnosis, Differential
1
2012
1508
0.070
 Why?
Telomere
3
2000
287
0.070
 Why?
Proto-Oncogene Proteins c-ret
2
2018
41
0.070
 Why?
beta Catenin
2
2023
254
0.070
 Why?
Maximum Tolerated Dose
2
2021
210
0.070
 Why?
Heart Neoplasms
1
2008
56
0.060
 Why?
Hematopoietic Stem Cell Transplantation
2
2024
699
0.060
 Why?
Follow-Up Studies
4
2021
5423
0.060
 Why?
DNA
1
2014
1435
0.060
 Why?
Pancreatic Neoplasms
1
2015
928
0.060
 Why?
Adolescent
6
2019
22529
0.060
 Why?
Reproducibility of Results
3
2019
3413
0.060
 Why?
Workflow
2
2017
183
0.060
 Why?
Eye Neoplasms
1
2005
30
0.060
 Why?
National Cancer Institute (U.S.)
1
2025
54
0.060
 Why?
Myasthenia Gravis
1
2025
24
0.060
 Why?
Internship and Residency
1
2016
1267
0.050
 Why?
Mental Disorders
1
2014
1163
0.050
 Why?
Polymorphism, Single Nucleotide
2
2025
2158
0.050
 Why?
Immunophenotyping
1
2005
319
0.050
 Why?
Pleura
1
2024
28
0.050
 Why?
Poly-ADP-Ribose Binding Proteins
1
2023
33
0.050
 Why?
DNA Polymerase II
1
2023
35
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2015
337
0.050
 Why?
Induction Chemotherapy
1
2024
88
0.050
 Why?
Administration, Oral
2
2018
866
0.050
 Why?
Peritoneum
1
2023
43
0.050
 Why?
Genes, ras
2
2015
96
0.050
 Why?
DNA Mismatch Repair
1
2023
53
0.050
 Why?
Leukocyte Count
1
2024
316
0.050
 Why?
Antigens, Differentiation, B-Lymphocyte
2
2013
36
0.050
 Why?
Blotting, Western
4
2015
1179
0.050
 Why?
Carcinoma, Endometrioid
1
2022
49
0.050
 Why?
Cell Survival
2
2017
1100
0.040
 Why?
Cell Cycle
2
2012
598
0.040
 Why?
Active Transport, Cell Nucleus
1
2002
117
0.040
 Why?
Histocompatibility Antigens Class II
2
2013
364
0.040
 Why?
Magnetic Resonance Imaging
1
2014
3904
0.040
 Why?
Gene Expression Regulation, Enzymologic
1
2002
267
0.040
 Why?
Gene Expression Profiling
2
2017
1767
0.040
 Why?
Models, Molecular
2
2018
1598
0.040
 Why?
Base Sequence
3
2017
2170
0.040
 Why?
Standard of Care
1
2020
81
0.040
 Why?
Mice
3
2026
18329
0.040
 Why?
Protein Processing, Post-Translational
1
2002
471
0.040
 Why?
Animals
6
2026
38030
0.040
 Why?
HSP90 Heat-Shock Proteins
1
1999
46
0.040
 Why?
Catalytic Domain
4
2000
234
0.040
 Why?
Fetus
1
2023
804
0.040
 Why?
Cell Nucleus
1
2002
588
0.040
 Why?
Time Factors
3
2020
7123
0.040
 Why?
Sequence Deletion
2
2014
190
0.030
 Why?
Aurora Kinase A
1
2018
61
0.030
 Why?
Radiotherapy, Image-Guided
1
2018
39
0.030
 Why?
Tumor Microenvironment
1
2023
734
0.030
 Why?
Cell Line
4
2012
2823
0.030
 Why?
RNA, Untranslated
1
1999
121
0.030
 Why?
Proto-Oncogenes
1
2018
28
0.030
 Why?
Cohort Studies
2
2019
6013
0.030
 Why?
Nausea
1
2018
112
0.030
 Why?
Cetuximab
1
2018
111
0.030
 Why?
Phthalazines
1
2018
63
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2017
28
0.030
 Why?
Breast
1
2018
156
0.030
 Why?
Diarrhea
1
2018
193
0.030
 Why?
Quality Control
1
2017
161
0.030
 Why?
Molecular Sequence Data
3
2013
2883
0.030
 Why?
A549 Cells
1
2017
75
0.030
 Why?
Pathology, Surgical
1
2016
6
0.030
 Why?
Child
5
2015
22707
0.030
 Why?
Structure-Activity Relationship
1
2018
563
0.030
 Why?
Risk Assessment
1
2026
3747
0.030
 Why?
Centrosome
1
2016
71
0.030
 Why?
Drug Synergism
1
2017
354
0.030
 Why?
Carcinoma
2
2012
225
0.030
 Why?
Fatigue
1
2018
364
0.030
 Why?
Dual Specificity Phosphatase 6
1
2015
5
0.030
 Why?
Consensus
1
2018
477
0.030
 Why?
Genes, erbB-1
1
2015
21
0.030
 Why?
Mice, Nude
1
2017
679
0.030
 Why?
Transcription, Genetic
1
2002
1454
0.030
 Why?
Lamin Type A
1
2015
49
0.030
 Why?
Cell Line, Transformed
3
2000
138
0.030
 Why?
Mitogen-Activated Protein Kinase Kinases
1
2015
126
0.030
 Why?
MAP Kinase Kinase 1
1
2015
70
0.030
 Why?
Multivariate Analysis
1
2018
1547
0.030
 Why?
Antimetabolites, Antineoplastic
1
2015
106
0.030
 Why?
Child, Preschool
3
2015
11853
0.030
 Why?
HEK293 Cells
1
2017
741
0.030
 Why?
Sequence Analysis, DNA
1
2017
777
0.030
 Why?
Respiratory Mucosa
1
2017
322
0.030
 Why?
Fluorodeoxyglucose F18
1
2015
161
0.030
 Why?
Radiopharmaceuticals
1
2015
205
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
376
0.030
 Why?
Recurrence
1
2017
1138
0.020
 Why?
Microdissection
1
2013
13
0.020
 Why?
Epidermal Growth Factor
1
2013
162
0.020
 Why?
Drug Administration Schedule
1
2015
782
0.020
 Why?
Syndecan-4
1
2012
6
0.020
 Why?
Disease Management
1
2017
653
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2015
440
0.020
 Why?
Papillomaviridae
1
2013
116
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2018
992
0.020
 Why?
Cooperative Behavior
1
2015
462
0.020
 Why?
Bone and Bones
1
2015
317
0.020
 Why?
Transcriptome
1
2018
1038
0.020
 Why?
Randomized Controlled Trials as Topic
1
2018
1747
0.020
 Why?
SMARCB1 Protein
1
2011
34
0.020
 Why?
Incidence
1
2018
2923
0.020
 Why?
Hyperglycemia
1
2015
379
0.020
 Why?
Green Fluorescent Proteins
1
2012
407
0.020
 Why?
Chromosomal Proteins, Non-Histone
1
2011
130
0.020
 Why?
Lymphatic Metastasis
1
2012
331
0.020
 Why?
Bronchoscopy
1
2012
227
0.020
 Why?
Adaptor Proteins, Signal Transducing
1
2013
425
0.020
 Why?
Enzyme Inhibitors
1
2014
820
0.020
 Why?
Pregnancy
1
2023
7202
0.020
 Why?
Infant
2
2015
10077
0.020
 Why?
Cognition Disorders
1
2014
541
0.020
 Why?
Retroviridae
2
2000
100
0.020
 Why?
Hypertension
1
2018
1273
0.020
 Why?
Reticulocytes
2
1999
17
0.020
 Why?
Protein Structure, Tertiary
1
2012
855
0.020
 Why?
Cells, Cultured
1
2017
4148
0.020
 Why?
Papillomavirus Infections
1
2013
344
0.020
 Why?
Sex Factors
1
2015
2105
0.020
 Why?
Genetic Vectors
2
2000
335
0.020
 Why?
Leukemic Infiltration
1
2008
11
0.020
 Why?
DNA Primers
2
1999
505
0.020
 Why?
Human T-lymphotropic virus 1
1
2008
32
0.020
 Why?
Rabbits
2
1999
652
0.020
 Why?
Longitudinal Studies
1
2015
2953
0.020
 Why?
In Vitro Techniques
2
1999
1048
0.020
 Why?
T-Lymphocytes
1
2016
1996
0.020
 Why?
National Institutes of Health (U.S.)
1
2008
147
0.020
 Why?
Phenotype
1
2015
3155
0.020
 Why?
Apoptosis
1
2015
2440
0.010
 Why?
Biomarkers
1
2017
4295
0.010
 Why?
Fibroblasts
2
2000
1025
0.010
 Why?
Transcription Factors
1
2011
1734
0.010
 Why?
Infant, Newborn
1
2013
6447
0.010
 Why?
Peptide Chain Termination, Translational
1
2000
9
0.010
 Why?
Fetal Proteins
1
2000
15
0.010
 Why?
Genes, Dominant
1
2000
100
0.010
 Why?
Chromosomes, Human
1
2000
44
0.010
 Why?
Fibrosarcoma
1
2000
23
0.010
 Why?
DNA, Complementary
1
2000
273
0.010
 Why?
Protein Subunits
1
2000
229
0.010
 Why?
Quinones
1
1999
11
0.010
 Why?
RNA-Directed DNA Polymerase
1
1999
35
0.010
 Why?
Lactams, Macrocyclic
1
1999
51
0.010
 Why?
Benzoquinones
1
1999
46
0.010
 Why?
Transfection
1
2000
926
0.010
 Why?
Cyclosporine
1
1999
256
0.010
 Why?
Carcinoma, Renal Cell
1
2000
230
0.010
 Why?
Half-Life
1
1997
155
0.010
 Why?
Neoplasm Proteins
1
2000
441
0.010
 Why?
Molecular Chaperones
1
1999
199
0.010
 Why?
RNA, Long Noncoding
1
1999
172
0.010
 Why?
Adenosine Triphosphate
1
1999
500
0.010
 Why?
Recombinant Proteins
1
1999
1368
0.010
 Why?
Skin
1
2000
753
0.010
 Why?
Flow Cytometry
1
1997
1162
0.010
 Why?
Prostatic Neoplasms
1
2000
978
0.010
 Why?
Aisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (418) concept(s)
_
Co-Authors Expand Description
See all (83) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)